Related Experiment Video
Updated: Jun 23, 2026
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
The link between obesity and albuminuria: adiponectin and podocyte dysfunction
1Center for Renal Translational Medicine, University of California, San Diego, La Jolla, CA/Veterans Administration San Diego Health Care System, La Jolla, California 92093-0711, USA. KumarSharma@ucsd.edu
Kidney International
|May 1, 2009
Summary
Obesity-related albuminuria is a growing concern for cardiovascular disease risk. The hormone adiponectin may be key, as it impacts kidney podocyte function and albuminuria development.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Disease
Background:
- Rising global obesity rates have increased obesity-related albuminuria.
- Albuminuria is a critical risk factor for cardiovascular disease.
- The precise mechanisms linking obesity and albuminuria require further elucidation.
Purpose of the Study:
- To explore the role of the adipocyte hormone adiponectin in obesity-related albuminuria.
- To understand adiponectin's influence on kidney podocyte function.
Main Methods:
- Clinical studies investigating adiponectin levels in obesity-related albuminuria.
- Studies utilizing adiponectin knockout mouse models to assess podocyte function.
Main Results:
- Adiponectin is implicated in the development of obesity-related albuminuria.
- Adiponectin influences podocyte function, contributing to initial albuminuria development.
Conclusions:
- Adiponectin plays a significant role in obesity-related albuminuria.
- Further research into renal adipocyte biology is crucial for developing preventive and therapeutic strategies.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:21External Anatomy of the Kidney
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...